Rigaku and Emerald Bio announce strategic alliance to broaden customer solutions in protein crystallography

July 31, 2013 – The Woodlands, TX. Rigaku, the leading supplier of X-ray instrumentation and automation equipment for structural biology, has acquired the crystallization reagent and consumable business, including the popular Wizard™ screens, from Emerald Bio, a world leader in protein science. In addition, both companies have agreed to work together to develop new products and solutions in the growing field of protein science.

“The addition of these consumables and screening kits is another step in creating a single contact point for our instrumentation customers, improving the efficiency of their workflow,” stated Catherine Klein, president of Rigaku Americas Corporation’s Life Sciences Division. “Further, having Emerald Bio as a development partner and customer will help ensure that we are at the forefront of new product needs in protein science.”

“Having Rigaku, the world leading protein crystallography instrumentation company, as a development partner is ideal for Emerald,” said Johan Pontin, CEO of Emerald Bio. “While we focus on our growing consulting solutions business,” said George Abe, president of Emerald Bio, “we can rely on Rigaku to support our own internal workflow needs and we now have a partner to build integrated solutions, including software, for our mutual customers.”

About Emerald:
Emerald Bio, The Protein Resource, operates as a contract research organization with vertical expertise in structural biology and protein resourcing. Emerald Bio offers structure-based drug discovery insight and expertise, innovative workflows, cutting edge specialty reagents and software to help solve our clients’ challenges connecting structure and function in protein science. We leverage our unique assets and know-how in biochemistry and structural biology to further our client’s understanding of proteins that ultimately leads to improved human health. Emerald Bio is a privately owned company that maintains facilities in Seattle and Boston. Emerald Bio is rapidly establishing itself as a leading global company in the area of membrane protein biology and chemistry, supporting leading research institutes with membrane protein tools and solutions that advance its customer’s scientific objectives.

For further information, contact:

Dr. Michael Willis
Rigaku
760-438-5282 x106
michael.willis@rigaku.com
George Abe
Emerald Bio
781-652-4002
gabe@embios.com